阻塞性睡眠呼吸暂停与心房颤动：我们需要一步一步来。
Obstructive sleep apnea and atrial fibrillation: we need to go step by step.
机构信息
Group of Precision Medicine in Chronic Diseases, Hospital Arnau de Vilanova and Santa Maria, IRBLleida, Lleida, Spain.
Centro de Investigación Biomédica en Red de Enfermedades Respiratorias, Madrid, Spain.
出版信息
J Clin Sleep Med. 2021 May 1;17(5):869-870. doi: 10.5664/jcsm.9242.
Abstract
Sánchez-de-la-Torre M, Lee C-H, Barbé F. Obstructive sleep apnea and atrial fibrillation: we need to go step by step. 2021;17(5):869–870.
摘要
桑切斯-德拉-托雷 M、李 C-H、巴贝 F. 阻塞性睡眠呼吸暂停与心房颤动：我们需要一步一步来。2021；17（5）：869-870.
相似文献
1
Obstructive sleep apnea and atrial fibrillation: we need to go step by step.阻塞性睡眠呼吸暂停与心房颤动：我们需要一步一步来。
J Clin Sleep Med. 2021 May 1;17(5):869-870. doi: 10.5664/jcsm.9242.
2
Obstructive sleep apnea in atrial fibrillation patients.心房颤动患者的阻塞性睡眠呼吸暂停
Int J Cardiol. 2006 Jun 28;110(3):426. doi: 10.1016/j.ijcard.2005.09.039. Epub 2005 Nov 23.
3
Diagnosed Sleep Apnea and Cardiovascular Disease in Atrial Fibrillation Patients: The Role of Measurement Error from Administrative Data.诊断睡眠呼吸暂停和心房颤动患者的心血管疾病：行政数据测量误差的作用。
Epidemiology. 2019 Nov;30(6):885-892. doi: 10.1097/EDE.0000000000001049.
4
Atrial fibrillation among patients under investigation for suspected obstructive sleep apnea.疑似阻塞性睡眠呼吸暂停患者中的心房颤动
PLoS One. 2017 Feb 8;12(2):e0171575. doi: 10.1371/journal.pone.0171575. eCollection 2017.
5
Prevalence of Atrial Fibrillation in Obstructive Sleep Apnea Patients in a Tertiary Care Center.在一家三级保健中心中阻塞性睡眠呼吸暂停患者中心房颤动的患病率。
JNMA J Nepal Med Assoc. 2020 Feb;58(222):80-83. doi: 10.31729/jnma.4812.
6
The role of obesity and sleep apnea in atrial fibrillation.肥胖和睡眠呼吸暂停在心房颤动中的作用。
Curr Opin Cardiol. 2011 Jan;26(1):40-5. doi: 10.1097/HCO.0b013e328341398e.
7
Screening for Obstructive Sleep Apnea in Patients with Atrial Fibrillation.心房颤动患者阻塞性睡眠呼吸暂停的筛查
Sleep Med Clin. 2017 Mar;12(1):99-105. doi: 10.1016/j.jsmc.2016.10.009. Epub 2016 Dec 20.
8
Risk factors for post coronary artery bypass graft atrial fibrillation: role of obstructive sleep apnea.冠状动脉搭桥术后房颤的危险因素：阻塞性睡眠呼吸暂停的作用。
Medwave. 2016 Dec 21;16(Suppl4):e6810. doi: 10.5867/medwave.2016.6810.
9
Kv1.5 blockers preferentially inhibit TASK-1 channels: TASK-1 as a target against atrial fibrillation and obstructive sleep apnea?Kv1.5阻滞剂优先抑制TASK-1通道：TASK-1作为治疗心房颤动和阻塞性睡眠呼吸暂停的靶点？
Pflugers Arch. 2015 May;467(5):1081-90. doi: 10.1007/s00424-014-1665-1. Epub 2014 Dec 17.
10
Obstructive sleep apnea and stroke risk in atrial fibrillation: Is there a correlation or not?阻塞性睡眠呼吸暂停与心房颤动中的中风风险：是否存在关联？
Int J Cardiol. 2015 Apr 1;184:306. doi: 10.1016/j.ijcard.2015.02.065. Epub 2015 Feb 25.
引用本文的文献
1
Linking Sleep Disorders to Atrial Fibrillation: Pathways, Risks, and Treatment Implications.将睡眠障碍与心房颤动相联系：途径、风险及治疗意义
Biology (Basel). 2024 Sep 25;13(10):761. doi: 10.3390/biology13100761.
2
The Impact of Atrial Fibrillation Treatment Strategies on Cognitive Function.心房颤动治疗策略对认知功能的影响。
J Clin Med. 2023 Apr 22;12(9):3050. doi: 10.3390/jcm12093050.
3
Diagnosis of Obstructive Sleep Apnea in Patients with Associated Comorbidity.伴有合并症的阻塞性睡眠呼吸暂停患者的诊断。
Adv Exp Med Biol. 2022;1384:43-61. doi: 10.1007/978-3-031-06413-5_4.
本文引用的文献
1
Clinical screening tools for obstructive sleep apnea in a population with atrial fibrillation: a diagnostic accuracy trial.临床筛查工具在心房颤动人群中的阻塞性睡眠呼吸暂停：一项诊断准确性试验。
J Clin Sleep Med. 2021 May 1;17(5):1015-1024. doi: 10.5664/jcsm.9098.
2
Randomized clinical trials of cardiovascular disease in obstructive sleep apnea: understanding and overcoming bias.随机对照临床试验在阻塞性睡眠呼吸暂停中的心血管疾病：理解和克服偏见。
Sleep. 2021 Feb 12;44(2). doi: 10.1093/sleep/zsaa229.
3
2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS): The Task Force for the diagnosis and management of atrial fibrillation of the European Society of Cardiology (ESC) Developed with the special contribution of the European Heart Rhythm Association (EHRA) of the ESC.2020年欧洲心脏病学会（ESC）与欧洲心胸外科学会（EACTS）合作制定的心房颤动诊断和管理指南：欧洲心脏病学会（ESC）心房颤动诊断和管理特别工作组，由ESC欧洲心律协会（EHRA）特别贡献制定。
Eur Heart J. 2021 Feb 1;42(5):373-498. doi: 10.1093/eurheartj/ehaa612.
4
Long-term Effect of CPAP Treatment on Cardiovascular Events in Patients With Resistant Hypertension and Sleep Apnea. Data From the HIPARCO-2 Study.持续气道正压通气治疗对高血压合并睡眠呼吸暂停患者心血管事件的长期影响。HIPARCO-2 研究的数据。
Arch Bronconeumol (Engl Ed). 2021 Mar;57(3):165-171. doi: 10.1016/j.arbres.2019.12.006. Epub 2020 Feb 3.
5
Effect of obstructive sleep apnoea and its treatment with continuous positive airway pressure on the prevalence of cardiovascular events in patients with acute coronary syndrome (ISAACC study): a randomised controlled trial.阻塞性睡眠呼吸暂停及其经持续气道正压通气治疗对急性冠状动脉综合征患者心血管事件发生率的影响（ISAACC 研究）：一项随机对照试验。
Lancet Respir Med. 2020 Apr;8(4):359-367. doi: 10.1016/S2213-2600(19)30271-1. Epub 2019 Dec 12.
6
Patient characteristics as predictors of recurrence of atrial fibrillation following cryoballoon ablation.作为冷冻球囊消融术后房颤复发预测因素的患者特征
Pacing Clin Electrophysiol. 2019 Jun;42(6):694-704. doi: 10.1111/pace.13669. Epub 2019 Apr 9.
7
The hypoxic burden of sleep apnoea predicts cardiovascular disease-related mortality: the Osteoporotic Fractures in Men Study and the Sleep Heart Health Study.睡眠呼吸暂停的低氧负荷可预测心血管疾病相关死亡率：男性骨质疏松性骨折研究和睡眠心脏健康研究。
Eur Heart J. 2019 Apr 7;40(14):1149-1157. doi: 10.1093/eurheartj/ehy624.
8
Sleep Apnea Increases the Risk of New Hospitalized Atrial Fibrillation: A Historical Cohort Study.睡眠呼吸暂停增加新发住院心房颤动的风险：一项历史性队列研究。
Chest. 2018 Dec;154(6):1330-1339. doi: 10.1016/j.chest.2018.08.1075. Epub 2018 Sep 19.
9
Effect of Obstructive Sleep Apnea Treatment on Atrial Fibrillation Recurrence: A Meta-Analysis.阻塞性睡眠呼吸暂停治疗对心房颤动复发的影响：一项荟萃分析。
JACC Clin Electrophysiol. 2015 Mar-Apr;1(1-2):41-51. doi: 10.1016/j.jacep.2015.02.014. Epub 2015 Apr 20.
10
Obstructive Sleep Apnea as a Risk Factor for Atrial Fibrillation: A Meta-Analysis.阻塞性睡眠呼吸暂停作为心房颤动的一个危险因素：一项荟萃分析。
J Sleep Disord Ther. 2018;7(1). doi: 10.4172/2167-0277.1000282. Epub 2018 Feb 12.
Zotero 插件